Volume 140, Issue 3, Pages e4 (March 2011)

Slides:



Advertisements
Similar presentations
Targeting Improves MSC Treatment of Inflammatory Bowel Disease
Advertisements

Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
Volume 145, Issue 6, Pages e8 (December 2013)
Volume 140, Issue 3, Pages e4 (March 2011)
Volume 149, Issue 1, Pages (July 2015)
Volume 33, Issue 3, Pages (September 2010)
Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4+ T Cells after Allogeneic Stem Cell Transplantation 
Volume 137, Issue 3, Pages (September 2009)
Volume 133, Issue 5, Pages (November 2007)
Volume 140, Issue 3, Pages e4 (March 2011)
Volume 143, Issue 5, Pages (November 2012)
Volume 78, Issue 11, Pages (December 2010)
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
Volume 136, Issue 4, Pages e3 (April 2009)
Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor Vaccine  Weiqing Jing,
Volume 149, Issue 1, Pages (July 2015)
Volume 136, Issue 3, Pages (March 2009)
Volume 20, Issue 8, Pages (August 2017)
Aryl Hydrocarbon Receptor Regulates Pancreatic IL-22 Production and Protects Mice From Acute Pancreatitis  Jing Xue, David T.C. Nguyen, Aida Habtezion 
Volume 143, Issue 5, Pages e4 (November 2012)
Redirection of Regulatory T Cells With Predetermined Specificity for the Treatment of Experimental Colitis in Mice  Eran Elinav, Tova Waks, Zelig Eshhar 
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
by Sheng F. Cai, Xuefang Cao, Anjum Hassan, Todd A
Targeting Improves MSC Treatment of Inflammatory Bowel Disease
Volume 145, Issue 6, Pages e8 (December 2013)
IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease after Bone Marrow Transplantation  Lucrezia Colonna, Mareike.
Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel Diseases  Zaruhi Hovhannisyan,
Volume 31, Issue 5, Pages (November 2009)
Volume 18, Issue 5, Pages (May 2010)
Volume 141, Issue 5, Pages (November 2011)
Volume 142, Issue 2, Pages e2 (February 2012)
Α-MSH-Stimulated Tolerogenic Dendritic Cells Induce Functional Regulatory T Cells and Ameliorate Ongoing Skin Inflammation  Matteo Auriemma, Thomas Brzoska,
Volume 135, Issue 3, Pages e5 (September 2008)
Inhibition of Cathepsin S Reduces Allogeneic T Cell Priming but Not Graft-versus-Host Disease Against Minor Histocompatibility Antigens  Hisaki Fujii,
Volume 128, Issue 5, Pages (May 2005)
Volume 140, Issue 7, Pages (June 2011)
Blocking Activator Protein 1 Activity in Donor Cells Reduces Severity of Acute Graft- Versus-Host Disease through Reciprocal Regulation of IL-17–Producing.
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 143, Issue 3, Pages e2 (September 2012)
Volume 13, Issue 1, Pages (January 2006)
Volume 143, Issue 1, Pages (July 2012)
Volume 141, Issue 5, Pages e2 (November 2011)
Volume 138, Issue 2, Pages (February 2010)
Volume 33, Issue 3, Pages (September 2010)
Volume 132, Issue 1, Pages (January 2007)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Qinglan Zhao, Yi Wei, Stephen J. Pandol, Lingyin Li, Aida Habtezion 
Volume 31, Issue 5, Pages (November 2009)
Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host.
Volume 135, Issue 5, Pages e5 (November 2008)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
Volume 29, Issue 6, Pages (December 2008)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 142, Issue 5, Pages (May 2012)
CpG-Induced Myeloid CD11b+Gr-1+ Cells Efficiently Suppress T Cell–Mediated Immunoreactivity and Graft-Versus-Host Disease in a Murine Model of Allogeneic.
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
Volume 38, Issue 3, Pages (March 2013)
Volume 139, Issue 2, Pages (August 2010)
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity  Jee H. Lee, Chris Elly,
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
Sibylle von Vietinghoff, Hui Ouyang, Klaus Ley  Kidney International 
Volume 20, Issue 1, Pages (January 2012)
Volume 28, Issue 5, Pages (May 2008)
Volume 136, Issue 7, Pages (June 2009)
Volume 131, Issue 6, Pages (December 2006)
Volume 149, Issue 1, Pages (July 2015)
Volume 37, Issue 2, Pages (August 2012)
Volume 10, Issue 5, Pages (February 2015)
Volume 25, Issue 3, Pages (September 2006)
Presentation transcript:

Volume 140, Issue 3, Pages 966-975.e4 (March 2011) Bone Marrow Stromal Cell Transplants Prevent Experimental Enterocolitis and Require Host CD11b+ Splenocytes  Biju Parekkadan, Rabi Upadhyay, Joshua Dunham, Yoshiko Iwamoto, Emiko Mizoguchi, Atsushi Mizoguchi, Ralph Weissleder, Martin L. Yarmush  Gastroenterology  Volume 140, Issue 3, Pages 966-975.e4 (March 2011) DOI: 10.1053/j.gastro.2010.10.013 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 Prevention of trinitrobenzosulfonic acid−induced colitis by MSC transplantation. (A) Kaplan–Meier analysis of cell-based transplantation strategies with intravenous treatment. (B) Percentage of original body weight loss of mice over time. (C) Semi-quantitative fecal occult blood testing of experimental groups. Fb, fibroblast; U, unit or the equivalent of 1 × 106 cells. For prevention studies, the cohorts were: ethanol sham (n = 4), 1 U MSC (n = 16), 0.25 U MSC (n = 8), saline (n = 15), or Fb (n = 6). *P < .05 and **P < .005. Gastroenterology 2011 140, 966-975.e4DOI: (10.1053/j.gastro.2010.10.013) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 Histopathological analysis of colitic mice after MSC infusion. Mesenteric lymph node (A) and transverse colon (B) of colitic mice 7 days post-cell therapy in the prevention trial. Lymph node cellularity and colon weight per length ratios are stated below the group names in units of [×106 cells/node] and [mg/cm], respectively. Representative microscopic specimens are shown for (C) saline, (D) fibroblast, and (E) MSC-treated colitic mice compared to (F) ethanol sham controls. Pathology scores are stated above the images. Histopathology analysis was performed on n = 4 of each group. EtOH, ethanol (sham control). Gastroenterology 2011 140, 966-975.e4DOI: (10.1053/j.gastro.2010.10.013) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 Increased regulatory T-cell number in mesenteric lymph nodes after MSC therapy. Flow cytometry of mesenteric lymph nodes for CD25 and Foxp3 expression. The graph represents 1 of 2 independent trials of n = 4. APC, allophycocyanin; EtOH, ethanol (sham control); Fb, fibroblast; PE, phycoerythrin; U, unit or the equivalent of 1 × 106 cells; WT, wild-type (healthy control). *P < .05. Gastroenterology 2011 140, 966-975.e4DOI: (10.1053/j.gastro.2010.10.013) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 Generation of Foxp3+ splenocytes after MSC coculture is dependent on CD11b+ Cells. Splenocytes were cultured for 5 days with or without mesenchymal cells at a 1:10 ratio (mesenchymal cell to splenocyte) and analyzed for Foxp3 expression using flow cytometry. Dot plots gated on CD4 expression of unfractionated splenocytes cultured with (A) IL-2 alone, (B) fibroblasts (Fb) and IL-2, or (C) MSCs and IL-2. The graph represents 1 of 5 independent trials. (D) Dot plot of CD11b+ depleted splenocytes cocultured with MSCs and IL-2. (E) Results of 5 independent trials comparing percentage of CD25+ Foxp3+ cells to coculture conditions. APC, allophycocyanin; PE, phycoerythrin. Gastroenterology 2011 140, 966-975.e4DOI: (10.1053/j.gastro.2010.10.013) Copyright © 2011 AGA Institute Terms and Conditions

Figure 5 Near infrared tracking of MSC transplants. MSCs were labeled with VT680 and infused intravenously at the time of trinitrobenzosulfonic acid administration. Control images, labeled as “dye,” are injections of VT680 dye alone. Representative images from the (A) lungs, (B) mesenteric lymph nodes, (C) large intestine, and (D) spleens of mice injected with the dye alone or labeled MSCs 1 day post-infusion. Results of 2 independent imaging studies of n = 3 per group. (E) Immunofluorescent micrographs of splenic tissue harvested from mice infused with VT680-labeled MSCs (red) and co-stained for CD11b (green), and 4′,6-diamidino-2-phenylindole (blue). Gastroenterology 2011 140, 966-975.e4DOI: (10.1053/j.gastro.2010.10.013) Copyright © 2011 AGA Institute Terms and Conditions

Figure 6 Depletion of CD11b+ cells by liposomal cytotoxicity or splenectomy eliminates the therapeutic effect of MSCs. (A) Kaplan–Meier analysis of TNBS-induced mice depleted of monocytes and macrophages by liposomal clodronate and intravenously treated with saline or MSCs. (B) Total number of CD25+ Foxp3+ cells in mesenteric lymph nodes after treatment of monocytic-depleted mice. (C) Kaplan–Meier analysis of TNBS-induced mice intravenously treated with saline or MSCs that were splenectomized before disease induction. (D) Total number of CD25+ Foxp3+ cells in mesenteric lymph nodes after treatment of splenectomized mice. Gastroenterology 2011 140, 966-975.e4DOI: (10.1053/j.gastro.2010.10.013) Copyright © 2011 AGA Institute Terms and Conditions

Figure 7 Adoptive transfer of CD11b+ splenocytes after MSC coculture confers increase in regulatory T-cell number and survival benefit in colitic mice. (A) Schematic of coculture composition. CD11b+ cells were isolated by magnetic activated cell sorting and directly cocultured with MSCs or fibroblasts for 5 days in vitro. Subsequently, CD11b+ cells were harvested by magnetic separation and were assessed for their immunomodulatory function in vitro and in vivo. (B) Box plots of CD25 and Foxp3 expression of splenocytes after incubation with cocultured CD11b+ cells (ratio denotes mesenchymal cell:splenocyte) for 5 days in regulatory T-cell stimulating conditions. The graph represents 1 of 2 independent trials of n = 3 wells. (C) Survival of TNBS−induced mice after treatment with cocultured CD11b+ cells at a 1-week study end point. n = 10 per group. (D) Total number of CD25+ Foxp3+ cells in mesenteric lymph nodes after treatment of colitic mice with transferred CD11b+ cells. Fb, fibroblast. U, unit or the equivalent of 1 × 106 cells. *P < .05. Gastroenterology 2011 140, 966-975.e4DOI: (10.1053/j.gastro.2010.10.013) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 1 Intraperitoneal delivery and therapeutic trials of MSC grafts in acute colitis. (A) Survival analysis of 0.25 U or 1 U MSCs injected intraperitoneally into colitic mice in a preventative setting. (B) Survival analysis and (C) body weight loss in experimental mice after intravenous delivery of cells at 2 days after disease onset. (D) Survival analysis and (E) body weight loss in experimental mice after intravenous delivery of cells at 1 day after disease onset. EtOH, ethanol (sham control); Fb, fibroblast; U, unit or the equivalent of 1 × 106 cells. **P < .005. Gastroenterology 2011 140, 966-975.e4DOI: (10.1053/j.gastro.2010.10.013) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 2 Generation of Foxp3+ splenocytes after MSC coculture is independent of enhanced proliferation of CD4+ CD25+ T cells or conversion of naïve cells to a suppressor phenotype. Dot plots gated on CD4 expression of CD4+ CD25− splenocytes were cultured for 5 days (A) with or (B) without MSCs and analyzed for Foxp3 expression using flow cytometry. The graph represents 1 of 3 independent trials of n = 4. (C) Total Foxp3+ cell number after coculture of magnetic activated cell sorting separated CD25+ cells with no cell, MSCs, or in the presence of recombinant human interleukin-2 for 5 days. After culture, cells were counted and analyzed for CD25+ Foxp3+ cells. The product of cell number and percentage of CD25+ Foxp3+ cell number is plotted as the absolute cell number for each condition. Gastroenterology 2011 140, 966-975.e4DOI: (10.1053/j.gastro.2010.10.013) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 3 Viability and intracellular fluorescence of MSCs loaded with VT680. (A) MSCs were incubated with VT680 at 0, 3, 30, and 300 mg/mL for 30 minutes on ice and viability was determined using trypan blue exclusion assay. (B) Representative histograms of VT680 expression by MSCs loaded with 0 (gray), 3 (blue), and 30 (red) mg/mL dye. Gastroenterology 2011 140, 966-975.e4DOI: (10.1053/j.gastro.2010.10.013) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 4 Splenic CD11b+ cells. (A) Immunofluorescent micrographs of wild-type splenic tissue stained for CD11b (green) and 4′,6-diamidino-2-phenylindole (blue). (B) Histogram of CD11b distribution in cells that were isolated after MSC in vitro coculture. (C) Dot plot of F4/80 and Gr-1 frequency in CD11b+ gated cells after MSC coculture. Gastroenterology 2011 140, 966-975.e4DOI: (10.1053/j.gastro.2010.10.013) Copyright © 2011 AGA Institute Terms and Conditions